ezetimibe has been researched along with d-alpha tocopherol in 9 studies
Studies (ezetimibe) | Trials (ezetimibe) | Recent Studies (post-2010) (ezetimibe) | Studies (d-alpha tocopherol) | Trials (d-alpha tocopherol) | Recent Studies (post-2010) (d-alpha tocopherol) |
---|---|---|---|---|---|
2,484 | 563 | 1,465 | 32,198 | 2,903 | 7,258 |
Protein | Taxonomy | ezetimibe (IC50) | d-alpha tocopherol (IC50) |
---|---|---|---|
Glutathione S-transferase P | Homo sapiens (human) | 0.5 |
Timeframe | Studies, this research(%) | All Research% |
---|---|---|
pre-1990 | 0 (0.00) | 18.7374 |
1990's | 0 (0.00) | 18.2507 |
2000's | 1 (11.11) | 29.6817 |
2010's | 8 (88.89) | 24.3611 |
2020's | 0 (0.00) | 2.80 |
Authors | Studies |
---|---|
Barnes, JC; Bradley, P; Day, NC; Fourches, D; Reed, JZ; Tropsha, A | 1 |
Chen, M; Hu, C; Suzuki, A; Thakkar, S; Tong, W; Yu, K | 1 |
Narushima, K; Suzuki, H; Takada, T; Yamanashi, Y | 1 |
Abuasal, B; Kaddoumi, A; Sylvester, PW | 1 |
Bott, R; Cantiello, M; Collet, X; Coméra, C; Goncalves, A; Nauze, M; Reboul, E; Soayfane, Z; Tercé, F | 1 |
Abuasal, BS; Kaddoumi, A; Qosa, H; Sylvester, PW | 1 |
Herbas, MS; Ishida, N; Kume, A; Shichiri, M; Suzuki, H | 1 |
Nashimoto, S; Sato, Y; Sugawara, M; Takekuma, Y | 1 |
Haraguchi, M; Kamishikiryo, J; Morita, T; Nakamura, T; Nakashima, S; Narahara, H; Sugihara, N; Tasaka, Y | 1 |
1 review(s) available for ezetimibe and d-alpha tocopherol
Article | Year |
---|---|
DILIrank: the largest reference drug list ranked by the risk for developing drug-induced liver injury in humans.
Topics: Chemical and Drug Induced Liver Injury; Databases, Factual; Drug Labeling; Humans; Pharmaceutical Preparations; Risk | 2016 |
8 other study(ies) available for ezetimibe and d-alpha tocopherol
Article | Year |
---|---|
Cheminformatics analysis of assertions mined from literature that describe drug-induced liver injury in different species.
Topics: Animals; Chemical and Drug Induced Liver Injury; Cluster Analysis; Databases, Factual; Humans; MEDLINE; Mice; Models, Chemical; Molecular Conformation; Quantitative Structure-Activity Relationship | 2010 |
Niemann-pick C1-like 1 mediates alpha-tocopherol transport.
Topics: alpha-Tocopherol; Animals; Anticholesteremic Agents; Azetidines; Biological Transport; Caco-2 Cells; Cholesterol; Cyclosporine; Ezetimibe; Humans; Immunohistochemistry; Intestinal Absorption; Male; Membrane Proteins; Membrane Transport Proteins; Micelles; Phosphatidylcholines; Rats; Rats, Wistar; Taurocholic Acid; Temperature; Time Factors; Vitamin A | 2008 |
Intestinal absorption of gamma-tocotrienol is mediated by Niemann-Pick C1-like 1: in situ rat intestinal perfusion studies.
Topics: Animals; Anticholesteremic Agents; Azetidines; Biological Transport; Chromans; Ezetimibe; Ileum; Intestinal Absorption; Intestinal Mucosa; Jejunum; Male; Niemann-Pick Diseases; Perfusion; Rats; Rats, Sprague-Dawley; Vitamin E | 2010 |
Respective contributions of intestinal Niemann-Pick C1-like 1 and scavenger receptor class B type I to cholesterol and tocopherol uptake: in vivo v. in vitro studies.
Topics: 4-Chloro-7-nitrobenzofurazan; Absorption; Animals; Azetidines; Bile Acids and Salts; Caco-2 Cells; Cell Membrane; Cholesterol; Chromatography, High Pressure Liquid; Cyclopentanes; Duodenum; Ezetimibe; gamma-Tocopherol; Gene Expression Profiling; Gene Expression Regulation; Humans; Jejunum; Lipid Metabolism; Membrane Transport Proteins; Mice; Mice, Inbred C57BL; Micelles; Scavenger Receptors, Class B; Thiosemicarbazones; Time Factors; Vitamin E | 2012 |
Comparison of the intestinal absorption and bioavailability of γ-tocotrienol and α-tocopherol: in vitro, in situ and in vivo studies.
Topics: Administration, Oral; alpha-Tocopherol; Animals; Area Under Curve; Azetidines; Biological Availability; Corn Oil; Drug Carriers; Ezetimibe; gamma-Tocopherol; In Vitro Techniques; Injections, Intravenous; Intestinal Absorption; Intestine, Small; Lipolysis; Male; Membrane Transport Proteins; Molecular Structure; Perfusion; Permeability; Rats; Rats, Sprague-Dawley; Solubility | 2012 |
Effect of anti-hyperlipidemia drugs on the alpha-tocopherol concentration and their potential for murine malaria infection.
Topics: alpha-Tocopherol; Animals; Anticholesteremic Agents; Antimalarials; Berberine; Cholestyramine Resin; Ezetimibe; Female; Malaria; Male; Mice; Mice, Inbred C57BL; Mice, Knockout; Parasitemia; Plasmodium yoelii; Probucol; Specific Pathogen-Free Organisms; Vitamin E Deficiency | 2016 |
Inhibitory effect of ezetimibe can be prevented by an administration interval of 4 h between α-tocopherol and ezetimibe.
Topics: alpha-Tocopherol; Animals; Anticholesteremic Agents; Antioxidants; Area Under Curve; Ezetimibe; Intestinal Absorption; Liver; Male; Rats; Rats, Wistar; Tissue Distribution | 2017 |
N-terminal domain of the cholesterol transporter Niemann-Pick C1-like 1 (NPC1L1) is essential for α-tocopherol transport.
Topics: alpha-Tocopherol; Animals; Anticholesteremic Agents; Binding, Competitive; Biological Transport; Caco-2 Cells; Cell Line, Tumor; Cholesterol; Endocytosis; Escherichia coli; Ezetimibe; Gene Expression; Genes, Reporter; Green Fluorescent Proteins; Hepatocytes; Humans; Membrane Proteins; Membrane Transport Proteins; Plasmids; Protein Binding; Protein Domains; Rats; Recombinant Fusion Proteins | 2017 |